Get the Weekly Intelligence Brief — top committee picks every Sunday.

ALC vs CDNA

Alcon Inc vs CareDx, Inc — AI-powered side-by-side comparison
ALC
Alcon Inc
68
Buy
VS
CDNA
CareDx, Inc
59
Buy
MetricALCCDNA
AI Score 68 59
Price $75.39 $47.20
P/E Ratio 45.39× 21.95×
ROE 4.4% -7.0%
Revenue Growth YoY
Gross Margin 54.9% 70.6%
Debt / Equity 0.24× 0.05×
Dividend Yield 0.5% 0.0%
RSI (14) 73.4 74.3
Beta 0.703 2.419
Expected Upside +11.3%

AI Committee View

Current Innellis committee reasoning for ALC versus CDNA.
ALC leads by 9 points.

ALC scores 68/100 (Buy) versus CDNA at 59/100 (Buy).

ALC Committee View
75% agreement
4 analysts

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
  • RSI at 73 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
CDNA Committee View
75% agreement
4 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 50.3% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • RSI at 74 is in overbought territory — Technical
  • Weekly RSI at 86 -- overbought on the larger timeframe too — Technical
  • Bollinger bandwidth of 50.3% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ALC Full Analysis CDNA Full Analysis